Cholesterol News and Research

RSS

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid.

New details on how low blood flow promotes vascular disease

Researchers have found the first direct proof that a key protein drives the clogging of arteries in two ways, and that lowering levels of it opens them up, according to study results published in the June edition of the journal Circulation.

24 Jun 2008

Study provides direct proof on how key protein promotes vascular disease

23 Jun 2008

New white wine as good for you as red!

Red wine is favoured by many health conscious tipplers because it contains higher levels of polyphenols - antioxidants which lower cholesterol and are thought to help prevent cancer.

23 Jun 2008

Ranbaxy and Pfizer settle on Lipitor patent litigation

Ranbaxy Laboratories Limited (Ranbaxy), announced today that it has entered into an agreement with Pfizer Inc. to settle most of the patent litigation worldwide involving Atorvastatin (Lipitor), the world's most-prescribed cholesterol-lowering medicine.

19 Jun 2008

Experts paint a depressing future for Australian diabetics

New research presented at an international conference has predicted that almost a third of Australians with diabetes will die from the disease in the next decade.

18 Jun 2008

Five common genetic variations linked to metabolic syndrome and HDL cholesterol levels

Nutrition researchers at Washington University School of Medicine in St. Louis have identified five common genetic variations that increase the risk of metabolic syndrome, a group of factors linked to heart disease and diabetes. Another variant they found appeared to protect against the condition.

17 Jun 2008

Like father like son - history of heart attacks in the family

Scientists know that heredity plays an important role in causing heart attacks. However the exact genetic mechanisms that transmit the risk of heart attacks from generation to generation still elude them.

17 Jun 2008

Lower incomes and lower education levels tied to higher death rates after heart attack

Researchers have long suspected that socioeconomic factors like education level and income also might affect survival rates following heart attack.

17 Jun 2008

Hearing loss twice as common in adults with diabetes

Hearing loss is about twice as common in adults with diabetes compared to those who do not have the disease, according to a new study funded by the National Institutes of Health (NIH).

16 Jun 2008

Diabetic women get less intense treatment of heart disease than men

Women with type 2 diabetes and heart disease have poorer control of both diseases and receive less intensive medical treatment than do men, a large new study found. The results have been presented Sunday, June 15, at The Endocrine Society’s 90th Annual Meeting in San Francisco.

16 Jun 2008

Campaign says heart disease a top killer of women as well as men

A campaign by the Australian Heart Foundation is aiming to debunk the myth that heart disease is a medical condition that primarily affects men.

16 Jun 2008

How to reduce obesity and cardiovascular disease risk

Changes in society are leading to a sedentary lifestyle and are causing a rise in the number of people with obesity and cardiovascular disease. This is consequently having a large impact on the health of the nation.

15 Jun 2008

EUROACTION Trial: A comprehensive approach to cardiovascular prevention

The single largest research project ever to be undertaken by the European Society of Cardiology (ESC), EUROACTION, showed that a multidisciplinary, family based and nurse coordinated programme made a real difference in improving lifestyle and reducing cardiovascular risk among coronary patients and people with a high risk of developing Cardiovascular Disease (CVD).

15 Jun 2008

Researchers find gamma-secretase modulators being tested for Alzheimer’s work in unexpected and beneficial ways

Researchers at Mayo Clinic, with their national and international collaborators, have discovered how a class of agents now in testing to treat Alzheimer's disease work, and say they may open up an avenue of drug discovery for this disease and others.

11 Jun 2008

Chinese red food colouring beats heart disease and cancer

According to a large study carried out in China, a red food colouring ingredient widely used in Chinese cooking protects against cancer and heart disease.

11 Jun 2008

Middle age smokers run the risk of memory loss and early dementia

The latest research adds to the long list of reasons why smokers should quit and is particularly bad news for middle-age smokers.

10 Jun 2008

Low levels of vitamin D in men linked to heart attack

Low levels of vitamin D appear to be associated with higher risk of myocardial infarction (heart attack) in men, according to a report in the June 9 issue of Archives of Internal Medicine.

9 Jun 2008

New perspective on coronary disease thanks to ultrasound

Compared to other techniques, Intravascular Ultrasound (IVUS) is much better at monitoring the increase or decrease of atherosclerosis in the coronary arteries. Can the method even be used to predict the odds of a heart attack or other cardiovascular event? Studies indicate this may be the case, states Professor Clemens von Birgelen in his inaugural address at the University of Twente.

5 Jun 2008

How the cholesterol-lowering drug ezetimibe (Zetia) works

A new study in the June issue of Cell Metabolism, a Cell Press publication, sheds light on the action of the drug ezetimibe (trade name Zetia), which is used to treat high cholesterol. Ezetimibe is unique among cholesterol-lowering drugs in that it works by cutting the amount of cholesterol taken in from the diet rather than by blocking cholesterol's manufacture in the body.

3 Jun 2008

How advanced prostate cancer becomes resistant to androgen-deprivation therapy

For the past 70 years the treatment of choice for advanced, metastatic prostate cancer has been androgen-deprivation therapy. That is, the suppression of circulating testosterone - the hormone that fuels prostate-cancer growth - via surgical castration (orchiectomy) or medical castration with testosterone-blocking drugs. While such therapy buys time for patients, it is not a cure, as inevitably the cancer becomes resistant to the androgen deprivation and continues to grow.

2 Jun 2008